Jan Johannessen - Feb 16, 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ William Solis, as Attorney-in-Fact for Jan Johannessen
Stock symbol
TWST
Transactions as of
Feb 16, 2022
Transactions value $
-$226,000
Form type
4
Date filed
2/18/2022, 03:35 PM
Previous filing
Feb 10, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Options Exercise $70K +5K +97.35% $14.00 10.1K Feb 16, 2022 Direct
transaction TWST Common Stock Sale -$296K -5K -49.33% $59.20 5.14K Feb 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Director Stock Option (right to buy) Options Exercise $0 -5K -18.31% $0.00 22.3K Feb 16, 2022 Common Stock 5K $14.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2021.
F2 1/3rd of the shares subject to the option vested and became exercisable on October 30, 2019, and 1/3rd of the shares subject to the option vest and become exercisable on each annual anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.